Summary of HR 5133: Patients’ Right to Know Their Medication Act of 2025

Bill Number: HR 5133

Title: Patients’ Right to Know Their Medication Act of 2025

Status: Introduced in House

Introduced Date: September 04, 2025

Classification: Bill

Purpose and Intent

The Patients’ Right to Know Their Medication Act of 2025 aims to enhance transparency in the healthcare system by ensuring that patients have access to comprehensive information about the medications they are prescribed. The bill seeks to empower patients to make informed decisions regarding their treatment options and to foster better communication between healthcare providers and patients.

Key Provisions

The bill includes several significant provisions designed to improve patient knowledge and engagement:

• Disclosure Requirements: Healthcare providers will be mandated to provide patients with detailed information about their prescribed medications, including:

  • The purpose of the medication
  • Potential side effects
  • Alternatives to the prescribed medication
  • Information on how to properly use the medication

• Patient Education Materials: The bill requires the development and distribution of educational materials that explain the medications in layman's terms, making it easier for patients to understand their treatment options.

• Informed Consent: The legislation emphasizes the importance of informed consent, ensuring that patients are fully aware of the implications of their medication choices before proceeding with treatment.

• Data Collection and Reporting: The bill proposes the establishment of a system for collecting data on patient outcomes related to medication adherence and understanding, which will be used to improve future healthcare practices.

Who Would Be Affected

The Patients’ Right to Know Their Medication Act of 2025 would primarily affect:

• Patients: Individuals receiving prescriptions will benefit from increased knowledge and understanding of their medications.
• Healthcare Providers: Physicians, pharmacists, and other healthcare professionals will need to adapt their practices to comply with the new disclosure requirements.
• Pharmaceutical Companies: Companies may be required to provide clearer information about their products to healthcare providers and patients.

Procedural Aspects

• Legislative Actions:
  • The bill was introduced in the House on September 04, 2025.
  • It has been referred to the House Committee on Energy and Commerce for further consideration.

Conclusion

The Patients’ Right to Know Their Medication Act of 2025 represents a significant step towards enhancing patient autonomy and informed decision-making in healthcare. By mandating clear communication about medications, the bill aims to improve patient outcomes and foster a more transparent healthcare environment. As the bill progresses through the legislative process, it will be essential to monitor its developments and potential impacts on the healthcare system.